Management of pulmonary edema and interstitial diseases of the lung is impaired by lack of accurate non-invasive means to monitor altered lung permeability and lung water content. In dogs and normal humans, we will evaluate a method to assess lung epithelial permeability from the rate of clearance from the lung of inhaled aerosols containing lipophobic radioactive tracers. Gamma cameras will be used to measure total and regional clearance rates. Rate of arrival in blood and non-pulmonary tissues will be monitored to detect altered permeability and the influence of background counts on observed lung clearance. Potential sources of variability in the technique such as aerosol size, site of deposition in the lungs, volume of gas in the lungs, and pulmonary vascular pressures will be determined in order to develop the most precise means to detect alterations from high permeability pulmonary edema and cardiogenic pulmonary edema. The index developed from these studies will be applied to patients with interstitial lung disease to see if it can supplement or replace bronchopulmonary lavage, gallium scans, and other means to detect alveolitis. The rebreathing method using soluble gases for non-invasively measuring lung water and cardiac output will be evaluated in normal humans using different breathing maneuvers and sampling techniques that will minimize errors from uneven distribution of the test gas in the lungs. The accuracy of this technique will be determined by making these measurements in patients with cardiopulmonary diseases having indicator dilution cardiac output measurements and chest computerized tomograms from which lung weight can be calculated. Tests of lung function in these patients including flow rates, indices of ventilation to volume mismatching, and impaired gas exchange will be analyzed to determine what degree of altered lung function causes significant errors in the rebreathing measurements of cardiac output and lung water. These studies are directed at defining the degree of cardiopulmonary dysfunction that does not interfere with non-invasive rebreathing measurements of cardiac output and lung water.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL016784-09
Application #
3335262
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1977-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Medicine
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Kallay, M C; Hyde, R W; Smith, R J (1990) Assessment of rebreathing O2 consumption in humans with normal and diseased lungs. J Appl Physiol 68:1443-52
Hall, S B; Notter, R H; Smith, R J et al. (1990) Altered function of pulmonary surfactant in fatty acid lung injury. J Appl Physiol 69:1143-9
Kallay, M C; Hyde, R W; Smith, R J et al. (1987) Cardiac output by rebreathing in patients with cardiopulmonary diseases. J Appl Physiol 63:201-10
Morrow, P E (1986) Factors determining hygroscopic aerosol deposition in airways. Physiol Rev 66:330-76
Wandtke, J C; Hyde, R W; Fahey, P J et al. (1986) Measurement of lung gas volume and regional density by computed tomography in dogs. Invest Radiol 21:108-17
Oberdorster, G; Utell, M J; Morrow, P E et al. (1986) Bronchial and alveolar absorption of inhaled 99mTc-DTPA. Am Rev Respir Dis 134:944-50
Walkenstein, M D; Peterson, B T; Gerber, J E et al. (1985) Histamine-induced pulmonary edema distal to pulmonary arterial occlusion. J Appl Physiol 58:1092-8
Kallay, M C; Hyde, R W; Fahey, P J et al. (1985) Effect of the rebreathing pattern on pulmonary tissue volume and capillary blood flow. J Appl Physiol 58:1881-94